Aprea Therapeutics Inc
(APRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APRE | AZN | AMGN | GILD | BMY |
| Company | Aprea Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.6600 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 0.6600 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 0.6000 | 190.98 | 369.93 | 150.47 | 60.55 |
| Latest | 0.6149 | 193.52 | 370.32 | 151.05 | 60.80 |
| Change | -0.0451 | +5.51 | -5.50 | -0.63 | +0.03 |
| % Change | -6.83% | +2.93% | -1.46% | -0.42% | +0.05% |
| Volume | 42,316 | 693,372 | 236,787 | 768,671 | 1,086,018 |
| 20-Day Average Volume | 6,063,213 | 4,588,889 | 3,002,016 | 7,861,919 | 13,052,794 |
| Previous Close | 0.6600 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7735 | 187.32 | 347.90 | 137.47 | 56.51 |
| 20-Day Raw Stochastic | 9.34% | 81.29% | 80.67% | 94.04% | 90.01% |
| 20-Day Relative Strength | 36.45 | 56.86 | 64.21 | 74.32 | 69.08 |
| Weighted Alpha | -81.43 | +36.36 | +35.41 | +54.31 | +25.68 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.54% since 02/03/26 | +4.47% since 02/03/26 | +10.01% since 02/03/26 | +5.51% since 02/03/26 | +9.31% since 02/03/26 |
| Low | 0.5706 on 02/09/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 0.7064 on 02/04/26 | 195.88 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -32.71% since 01/09/26 | +1.72% since 01/09/26 | +14.23% since 01/09/26 | +24.83% since 01/09/26 | +9.56% since 01/09/26 |
| Low | 0.5480 on 01/29/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 1.4900 on 01/30/26 | 195.88 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -49.92% since 11/10/25 | +10.05% since 11/10/25 | +15.09% since 11/10/25 | +27.95% since 11/10/25 | +29.50% since 11/10/25 |
| Low | 0.5480 on 01/29/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 1.4900 on 01/30/26 | 195.88 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -62.59% since 08/08/25 | +30.90% since 08/08/25 | +29.23% since 08/08/25 | +26.60% since 08/08/25 | +33.19% since 08/08/25 |
| Low | 0.5480 on 01/29/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.7932 on 08/14/25 | 195.88 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,616 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 6,994 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 1,500,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -12,960,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 120,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,240,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.48 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 11/12/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/24/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.12 | 17.59 | 18.62 | 10.08 |